Pine Belt Mental Healthcare Resources
1104 Cedar Street
Suite B
Waynesboro, MS 39367
(601) 735-3350
Hotline: (888) 330-7772
Call
888-647-0579
to speak with an alcohol or drug abuse counselor.
Who Answers?
Treatment & Detox Guide
Medicines derived from cannabis: A review of adverse events
Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events. Several drugs containing compounds derived from the cannabis plant, or cannibinoids, are….
Younger Alcoholic Men at Risk for Osteoporosis
Low bone mass, or osteoporosis, is a known consequence of alcoholism, especially in older alcoholics. However, a new study shows that younger male alcoholics are also at increased risk for osteoporosis. People with osteoporosis, no matter what the cause, are at an increased risk for fractures and poor fracture healing. “Our study indicates malnutrition, little….
Sobriety leads to new role as a guide
Marilu Thornburgh’s outgoing personality has been built upon a survivor’s instinct. There was a time when her world was perilously close to collapse. A time when co-dependency and her subsequent descent into alcoholism prevailed. But Thornburgh did survive, she got help to overcome her problems and has been sober since the 1990s. Now she readily….
Seizure drug shows promise as potential therapy for alcoholism
A new study conducted on mice has shown that a seizure drug, called gabapentin, could act as a potential therapy for alcoholism by reversing cellular effects. In the study, alcohol-dependent rodents receiving gabapentin drank less alcohol, and this led the scientists to say that gabapentin normalizes the action of certain brain cells altered by chronic….
Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer
New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of….